This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Medtronic Wins Patent Case

An arbitration panel has found in favor of Medtronic (MDT - Get Report) in a patent case in which it had been sued by Johnson & Johnson (JNJ - Get Report) and J&J's Cordis medical-device division.

J&J and its unit alleged that the Medtronic Driver stent and several other products infringed certain Cordis patents. The arbitration panel issued a nonappealable decision on Feb. 20 and the award became final on March 22, Medtronic said.

Separately, a stay has been lifted in a patent infringement lawsuit Medtronic had filed against J&J and Cordis. In that case, Medtronic is alleging that the Cordis Cypher stent is infringing its Fitzmaurice catheter-design patents.

The case had been on stay pending the outcome of the arbitration panel's decision. The stay was lifted March 2, and a trial will be scheduled.

Shares of Medtronic were down 24 cents at $53.59, and J&J was lower by 26 cents at $60.74.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
JNJ $102.37 0.40%
MDT $76.46 -0.13%
AAPL $117.81 -0.19%
FB $105.45 0.04%
GOOG $750.26 0.28%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs